Omega-3 fatty acid status in attention-deficit/hyperactivity disorder

被引:129
作者
Antalis, Caryl J.
Stevens, Laura J.
Campbell, Mary
Pazdro, Robert
Ericson, Karen
Burgess, John R. [1 ]
机构
[1] Purdue Univ, Dept Foods & Nutr, W Lafayette, IN 47909 USA
[2] Purdue Univ, Counseling & Psychol Serv, W Lafayette, IN 47909 USA
[3] Indiana Univ Purdue Univ, Dept Chem, Ft Wayne, IN 46805 USA
来源
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS | 2006年 / 75卷 / 4-5期
关键词
D O I
10.1016/j.plefa.2006.07.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lower levels of long-chain polyunsaturated fatty acids, particularly omega-3 fatty acids, in blood have repeatedly been associated with a variety of behavioral disorders including attention-deficit/hyperactivity disorder (ADHD). The exact nature of this relationship is not yet clear. We have studied children with ADHD who exhibited skin and thirst symptoms classically associated with essential fatty acid (EFA) deficiency, altered plasma and red blood cell fatty acid profiles, and dietary intake patterns that do not differ significantly from controls. This led us to focus on a potential metabolic insufficiency as the cause for the altered fatty acid phenotype. Here we review previous work and present new data expanding our observations into the young adult population. The frequency of thirst and skin symptoms was greater in newly diagnosed individuals with ADHD (n = 35) versus control individuals without behavioral problems (n = 112) drawn from the Purdue student population. A follow up case-control study with participants willing to provide a blood sample, a urine sample, a questionnaire about their general health, and dietary intake records was conducted with balancing based on gender, age, body mass index, smoking and ethnicity. A number of biochemical measures were analyzed including status markers for several nutrients and antioxidants, markers of oxidative stress, inflammation markers, and fatty acid profiles in the blood. The proportion of omega-3 fatty acids was found to be significantly lower in plasma phospholipids and erythrocytes in the ADHD group versus controls whereas saturated fatty acid proportions were higher. Intake of saturated fat was 30% higher in the ADHD group, but intake of all other nutrients was not different. Surprisingly, no evidence of elevated oxidative stress was found based on analysis of blood and urine samples. Indeed, serum ferritin, magnesium, and ascorbate concentrations were higher in the ADHD group, but iron, zinc, and vitamin 136 were not different. Our brief survey of biochemical and nutritional parameters did not give us any insight into the etiology of lower omega-3 fatty acids, but considering the consistency of the observation in multiple ADHD populations continued research in this field is encouraged. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:299 / 308
页数:10
相关论文
共 82 条
  • [1] Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: A double blind and randomized trial [ISRCTN64132371]
    Akhondzadeh, Shahin
    Mohammadi, Mohammad-Reza
    Khademi, Mojgan
    [J]. BMC PSYCHIATRY, 2004, 4 (1)
  • [2] The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients The possible role of oxidant/antioxidant imbalance
    Akyol, Ö
    Herken, H
    Uz, E
    Fadillioglu, E
    Ünal, S
    Sögüt, S
    Özyurt, H
    Savas, HA
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2002, 26 (05) : 995 - 1005
  • [3] THE EFFECTS OF ESSENTIAL FATTY-ACID SUPPLEMENTATION BY EFAMOL IN HYPERACTIVE-CHILDREN
    AMAN, MG
    MITCHELL, EA
    TURBOTT, SH
    [J]. JOURNAL OF ABNORMAL CHILD PSYCHOLOGY, 1987, 15 (01) : 75 - 90
  • [4] [Anonymous], ATTENTION DEFICIT HY
  • [5] Zinc in attention-deficit/hyperactivity disorder
    Arnold, LE
    DiSilvestro, RA
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2005, 15 (04) : 619 - 627
  • [6] Serum zinc correlates with parent- and teacher-rated inattention in children with attention-deficit/hyperactivity disorder
    Arnold, LE
    Bozzolo, H
    Hollway, J
    Cook, A
    DiSilvestro, RA
    Bozzolo, DR
    Crowl, L
    Ramadan, Y
    Williams, C
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2005, 15 (04) : 628 - 636
  • [7] Attention-deficit hyperactivity disorder
    Biederman, J
    Faraone, SV
    [J]. LANCET, 2005, 366 (9481) : 237 - 248
  • [8] Burgess JR, 2000, AM J CLIN NUTR, V71, p327S, DOI 10.1093/ajcn/71.1.327S
  • [9] BURGESS JR, 2003, PHOSPHOLIPID SPECTRU
  • [10] Burr GO, 1930, J BIOL CHEM, V86, P0587